Matthew J Ferris (Robert Ferris, Robert L Ferris, R L Ferris)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 54

Top Venues

Cancer

Head & neck

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

University of Pittsburgh School of Medicine

Johns Hopkins School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh School of Medicine

United States

UPMC Endowed Professor :: Otolaryngology

University of Pittsburgh Cancer Institute

United States

Associate Director for Translational Research

University of Pittsburgh School of Medicine

United States

Vice-Chair for Clinical Operations :: Otolaryngology

University of Pittsburgh Cancer Institute

United States

Co-leader :: Cancer Immunology Program

University of Pittsburgh School of Medicine

United States

Chief :: Otolaryngology, Division of Head and Neck Surgery

Education History

Johns Hopkins School of Medicine

United States

PHD

Publications

Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) 20 (12) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) 20 (12) (2024)
Kevin A Contrera, Mihir R Patel, Barbara A Burtness, Ranee Mehra, Matthew J Ferris
The role of surgery and deescalation for HPV-related oropharyngeal cancer. Cancer (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) 20 (12) (2024)
Matthew J Ferris, Hisham Mehanna, Jonathan D Schoenfeld, Makato Tahara, Sue S Yom, Robert I Haddad, André König, Pauline Witzler, Marcis Bajars, Christophe Le Tourneau
Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN: the phase III XRay Vision study design. Future oncology (London, England) (2024)
Kevin A Contrera, Mihir R Patel, Barbara A Burtness, Ranee Mehra, Matthew J Ferris
The role of surgery and deescalation for HPV-related oropharyngeal cancer. Cancer (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Nikhil I Khushalani, Patrick A Ott, Matthew J Ferris, Tina Cascone, Dirk Schadendorf, Dung T Le, Manish R Sharma, Fabrice Barlesi, William Sharfman, Jason John Luke, Ignacio Melero Bermejo, Deanne Lathers, Jaclyn Neely, Satyendra Suryawanshi, Abanti Sanyal, James L Holloway, Rasika Suryawanshi, Scott Ely, Neil H Segal
Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 12 (3) (2024)
Marco Antonio Mascarella, Tolani F Olonisakin, Purva H Rumde, Varun Vendra, Melonie A Nance, Seungwon Kim, Mark W Kubik, Shaum S Sridharan, Matthew J Ferris, Moon J Fenton, Daniel R Clayburgh, James P Ohr, Sonali C Joyce, Malabika Sen, James G Herman, Jennifer R Grandis, Dan P Zandberg, Umamaheswar Duvvuri
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Marco Antonio Mascarella, Tolani F Olonisakin, Purva H Rumde, Varun Vendra, Melonie A Nance, Seungwon Kim, Mark W Kubik, Shaum S Sridharan, Matthew J Ferris, Moon J Fenton, Daniel R Clayburgh, James P Ohr, Sonali C Joyce, Malabika Sen, James G Herman, Jennifer R Grandis, Dan P Zandberg, Umamaheswar Duvvuri
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (4) (2023)
Sophie Wildsmith, Weimin Li, Song Wu, Ross Stewart, Nassim Morsli, Rajiv Raja, Qu Zhang, Jiabu Ye, Philip He, Jagdish Shetty, Alejandro Yovine, Nicholas Holoweckyj, Katia Real, Jill Walker, Magdalena Wrona, Melissa de Los Reyes, Craig Barker, Jessica Whiteley, Robert I Haddad, Lisa F Licitra, Matthew J Ferris, Jérôme Fayette, Dan P Zandberg, Lillian L Siu, Ricard Mesía
Tumor Mutational Burden as a Predictor of Survival With Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Feng Shan, Anthony R Cillo, Carly Cardello, Daniel Y Yuan, Sheryl R Kunning, Jian Cui, Caleb Lampenfeld, Asia M Williams, Alexandra P McDonough, Arjun Pennathur, James D Luketich, Joanne M Jeter, Matthew J Ferris, Tullia C Bruno, Creg J Workman, Panayiotis V Benos, Dario A A Vignali
Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells. Science immunology 8 (87) (2023)
Marco Antonio Mascarella, Tolani F Olonisakin, Purva H Rumde, Varun Vendra, Melonie A Nance, Seungwon Kim, Mark W Kubik, Shaum S Sridharan, Matthew J Ferris, Moon J Fenton, Daniel R Clayburgh, James P Ohr, Sonali C Joyce, Malabika Sen, James G Herman, Jennifer R Grandis, Dan P Zandberg, Umamaheswar Duvvuri
Response to neoadjuvant targeted therapy in operable head and neck cancer confers survival benefit. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Huaibin Ge, Matthew J Ferris, Jing Hong Wang
Cetuximab responses in HNSCC patients correlate to clonal expansion feature of peripheral and tumor-infiltrating T cells with top T cell receptor (TCR) clonotypes. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Michael B Atkins, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Michael R Bishop, Daniel C Chen, Madhav Dhodapkar, Leisha A Emens, Marc S Ernstoff, Matthew J Ferris, Tim F Greten, James L Gulley, Roy S Herbst, Rachel W Humphrey, James Larkin, Kim A Margolin, Luca Mazzarella, Suresh S Ramalingam, Meredith M Regan, Brian I Rini, Mario Sznol
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC). Journal for immunotherapy of cancer 10 (9) (2022)
Robert I Haddad, Kevin J Harrington, Makato Tahara, Matthew J Ferris, Maura Gillison, Jerome Fayette, Amaury Daste, Piotr Koralewski, Bogdan Zurawski, Miren Taberna, Nabil F Saba, Milena Perez Mak, Andrzej Kawecki, Gustavo C Girotto, Miguel Angel Alvarez Avitia, Caroline Even, Joaquin Gabriel Reinoso Toledo, Alexander D Guminski, Urs D A Müller-Richter, Naomi Kiyota, Mustimbo Roberts, Tariq Aziz Khan, Karen Miller-Moslin, Li Wei, Athanassios Argiris
Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Ayana T Ruffin, Housaiyin Li, Lazar Vujanovic, Dan P Zandberg, Matthew J Ferris, Tullia C Bruno
Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment. Nature reviews. Cancer (2022)
Ashwin S Somasundaram, Anthony R Cillo, Caleb Lampenfeld, Creg J Workman, Sheryl R Kunning, Lauren Oliveri, Maria A Velez, Sonali C Joyce, Michael J Calderon, Rebekah Dadey, Dhivyaa Rajasundaram, Daniel P Normolle, Simon C Watkins, James G Herman, Joanne M Jeter, Evan J Lipson, Matthew J Ferris, Tullia C Bruno, Dario A A Vignali
Systemic Immune Dysfunction in Cancer Patients Driven by IL6 Induction of LAG3 in Peripheral CD8+ T Cells. Cancer immunology research 10 (7) (2022)
Matthew J Ferris, Barbara A Burtness, Yael Flamand
Reply to A.S. Garden. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2022)
Chloe S Lalonde, Yong Teng, Barbara A Burtness, Matthew J Ferris, Rajesh M Valanparambil, Nabil F Saba
The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss. Journal of the National Cancer Institute 114 (10) (2022)
Anthony J Cmelak, Matthew J Ferris, Allen M Chen, Tanguy Y Seiwert, Barbara Burtness
Treatment De-intensification for HPV-Positive Oropharynx Cancer: What Is Currently Acceptable? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (24) (2021)
Lauren Ottenstein, Hannah Cornett, Jeffrey M Switchenko, Meghana Nathan, Susan Thomas, Amanda I Gillespie, Nancy McColloch, Tiffany Barrett, Matthew B Studer, Meghan Brinkman, Azeem S Kaka, Brian J Boyce, Matthew J Ferris, Ashley H Aiken, Mark El-Deiry, Jonathan J Beitler, Mihir R Patel
Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma. Head & neck 43 (5) (2021)
Weiwei Guo, Yue Wang, Min Yang, Zehua Wang, Yifei Wang, Smriti Chaurasia, Zhiyuan Wu, Min Zhang, Ghanshyam Singh Yadav, Sanjay Rathod, Fernando Concha-Benavente, Christian Fernandez, Song Li, Wen Xie, Matthew J Ferris, Udai S Kammula, Binfeng Lu, Da Yang
LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance. Science advances 7 (7) (2021)
Linwah Yip, William E Gooding, Alyaksandr Nikitski, Abigail I Wald, Sally E Carty, Esra Karslioglu-French, Raja R Seethala, Dan P Zandberg, Matthew J Ferris, Marina N Nikiforova, Yuri E Nikiforov
Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case-control study. Cancer 127 (11) (2021)
Khalil Baddour, Mark Fadel, Meng Zhao, Michael Corcoran, Maryanna S Owoc, Teresa H Thomas, Lindsay M Sabik, Marci L Nilsen, Matthew J Ferris, Leila J Mady
The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors. Head & neck 43 (10) (2021)
Stephen Y Lai, Matthew J Ferris
Reply to N. Hirshoren et al and D. Chakrabarti et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
Christopher W Noel, David Forner, David P Goldstein, Ur Metser, Matthew J Ferris, John Waldron, John R De Almeida
Elective neck dissection versus positron emission tomography-computed tomography-guided management of the neck in clinically node-negative early oral cavity cancer: A cost-utility analysis. Cancer 127 (12) (2021)
Matthew J Ferris, William C Spanos, Rom S Leidner, Anthony Gonçalves, Uwe M Martens, Chrisann Kyi, William Sharfman, Christine H Chung, Lot A Devriese, Helene Gauthier, Simon I Chiosea, Lazar Vujanovic, Janis M Taube, Julie E Stein, Jun Li, Bin Li, Tian Chen, Adam Barrows, Suzanne L Topalian
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial. Journal for immunotherapy of cancer 9 (6) (2021)
Meghan T Turner, Mathew N Geltzeiler, Jad Ramadan, Jessica M Moskovitz, Matthew J Ferris, Eric W Wang, Seungwon Kim
The Nasoseptal Flap for Reconstruction of Lateral Oropharyngectomy Defects: A Clinical Series. The Laryngoscope (2021)
Matthew J Ferris, Yael Flamand, Gregory S Weinstein, Shuli Li, Harry Quon, Ranee Mehra, Joaquin J Garcia, Christine H Chung, Maura L Gillison, Umamaheswar Duvvuri, Bert W O'Malley, Enver Ozer, Giovana R Thomas, Wayne M Koch, Neil D Gross, Richard B Bell, Nabil F Saba, Miriam N Lango, Eduardo Méndez, Barbara A Burtness
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Matthew J Ferris
Promising progress from Healthy People 2020 and cancer incidence update. Cancer 126 (10) (2020)
Harish Dharmarajan, Jennifer L Anderson, Seungwon Kim, Shaum Sridharan, Umamaheswar Duvvuri, Matthew J Ferris, Mario G Solari, David A Clump, Heath D Skinner, James P Ohr, Dan P Zandberg, Barton Branstetter, Marion A Hughes, Katie S Traylor, Raja Seethala, Simion I Chiosea, Marci L Nilsen, Jonas T Johnson, Mark W Kubik
Transition to a virtual multidisciplinary tumor board during the COVID-19 pandemic: University of Pittsburgh experience. Head & neck 42 (6) (2020)
Viran Ranasinghe, Leila J Mady, Seungwon Kim, Matthew J Ferris, Umamaheswar Duvvuri, Jonas T Johnson, Mario G Solari, Shaum Sridharan, Mark W Kubik
Major head and neck reconstruction during the COVID-19 pandemic: The University of Pittsburgh approach. Head & neck 42 (6) (2020)
Stephen Y Lai, Matthew J Ferris
Evolving Evidence in Support of Sentinel Lymph Node Biopsy for Early-Stage Oral Cavity Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (34) (2020)
Khalil Baddour, Lauren D Kudrick, Aakriti Neopaney, Lindsay M Sabik, Shyamal D Peddada, Marci L Nilsen, Jonas T Johnson, Matthew J Ferris, Leila J Mady
Potential impact of the COVID-19 pandemic on financial toxicity in cancer survivors. Head & neck 42 (6) (2020)
Chia-Jui Yen, Naomi Kiyota, Nobuhiro Hanai, Shunji Takahashi, Tomoya Yokota, Shigemichi Iwae, Yasushi Shimizu, Ruey-Long Hong, Masahiro Goto, Jin-Hyoung Kang, Wing Sum Kenneth Li, Matthew J Ferris, Maura Gillison, Toshimitsu Endo, Vijayvel Jayaprakash, Makoto Tahara
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141). Head & neck 42 (10) (2020)
Andrew B Tassler, William E Gooding, Matthew J Ferris
Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit? Head & neck 41 (7) (2019)
Daniel L Faden, Fernando Concha-Benavente, Anish B Chakka, Elizabeth L McMichael, Uma Chandran, Matthew J Ferris
Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma. Head & neck 41 (8) (2019)
Shaum Sridharan, Lester D R Thompson, Bibianna Purgina, Charles D Sturgis, Akeesha A Shah, Brian Burkey, Madalina Tuluc, David Cognetti, Bin Xu, Kevin Higgins, Juan C Hernandez-Prera, Dominick Guerrero, Manish M Bundele, Seungwon Kim, Umamaheswar Duvvuri, Matthew J Ferris, William E Gooding, Simion I Chiosea
Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: A model predicting local control and vetting of the eighth edition of the American Joint Committee on Cancer pathologic T stage. Cancer 125 (18) (2019)
Matthew J Ferris, Yuri E Nikiforov, Gregory Randolph
Response to Letter to the Editor regarding follow-up for NIFTP. Head & neck 41 (3) (2019)
Robert Haddad, Fernando Concha-Benavente, George Blumenschein, Jerome Fayette, Joel Guigay, A Dimitrios Colevas, Lisa Licitra, Stefan Kasper, Everett E Vokes, Francis Worden, Nabil F Saba, Makoto Tahara, Vijayvel Jayaprakash, Mark Lynch, Li Li, Maura L Gillison, Kevin J Harrington, Matthew J Ferris
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial. Cancer 125 (18) (2019)
Sibo Tian, Jeffrey M Switchenko, Jaymin Jhaveri, Richard J Cassidy, Matthew J Ferris, Robert H Press, Neil T Pfister, Mihir R Patel, Nabil F Saba, Mark W McDonald, Kristin A Higgins, David S Yu, Walter J Curran, Theresa W Gillespie, Jonathan J Beitler
Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base. Cancer 125 (16) (2019)
David Goldenberg, Matthew J Ferris, Maisie L Shindo, Ashok Shaha, Brendan C Stack, Ralph P Tufano
Thyroidectomy in patients who have undergone gastric bypass surgery. Head & neck 40 (6) (2018)
John D Cramer, Sedona E Speedy, Matthew J Ferris, Alfred W Rademaker, Urjeet A Patel, Sandeep Samant
National evaluation of multidisciplinary quality metrics for head and neck cancer. Cancer 123 (22) (2017)
William G Albergotti, Jessica Jordan, Keely Anthony, Shira Abberbock, Tamara Wasserman-Wincko, Seungwon Kim, Matthew J Ferris, Umamaheswar Duvvuri
A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx. Cancer 123 (16) (2017)
Krystle A Lang Kuhs, Aimée R Kreimer, Sumita Trivedi, Dana Holzinger, Michael Pawlita, Ruth M Pfeiffer, Sandra P Gibson, Nicole C Schmitt, Allan Hildesheim, Tim Waterboer, Matthew J Ferris
Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence. Cancer 123 (22) (2017)
Frederico O Gleber-Netto, Mei Zhao, Sanchit Trivedi, Jiping Wang, Samar Jasser, Christina McDowell, Humam Kadara, Jiexin Zhang, Jing Wang, William N William, J Jack Lee, Minh Ly Nguyen, Sara I Pai, Heather M Walline, Dong M Shin, Matthew J Ferris, Thomas E Carey, Jeffrey N Myers, Curtis R Pickering, null null
Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer 124 (1) (2017)
Tanya J Rath, S Narayanan, M A Hughes, Matthew J Ferris, Simion I Chiosea, Barton F Branstetter
Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma. AJNR. American journal of neuroradiology 38 (7) (2017)
Simion I Chiosea, Lester D R Thompson, Ilan Weinreb, Julie E Bauman, Alyssa M Mahaffey, Caitlyn Miller, Matthew J Ferris, William E Gooding
Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Cancer 122 (20) (2016)
Julie E Bauman, Ezra Cohen, Matthew J Ferris, David J Adelstein, David M Brizel, John A Ridge, Brian O'Sullivan, Barbara A Burtness, Lisa H Butterfield, William E Carson, Mary L Disis, Bernard A Fox, Thomas F Gajewski, Maura L Gillison, James W Hodge, Quynh-Thu Le, David Raben, Scott E Strome, Jean Lynn, Shakun Malik
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer 123 (7) (2016)

Matthew J Ferris.css-eqlu8i{font-size:small;padding-left:4px;} (Robert Ferris, Robert L Ferris, R L Ferris)

Publication Activity (10 Years)

Top Topics

Top Venues

Matthew J Ferris (Robert Ferris, Robert L Ferris, R L Ferris)